USP and Public Policy
Left
Refine Your Search
Compounding of medicines has a longstanding history and remains an important aspect of pharmacy practice. USP compounding standards serve as an integral part of the legal and regulatory frameworks…
Learn More
USP supports a comprehensive public policy framework to combat substandard and falsified medicines, including advancing stewardship of quality pharmaceutical products and practices, and building the…
Learn More
USP appreciates the opportunity to provide comments on FDA’s draft guidance, “Compounding Animal Drugs from Bulk Drug Substances.”
Learn More
USP appreciates the opportunity to comment on the Food and Drug Administration's (FDA) revised draft guidance on " appreciates the opportunity to comment on the Food and Drug Administration…
Learn More
USP welcomes the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) concerning approaches around the national opioid crisis.
Learn More
USP appreciates the opportunity to comment on the Food and Drug Administration's (FDA) issuance of the List of Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With…
Learn More
USP appreciates the opportunity to provide comments to the Food and Drug Administration (FDA) on the “Compounding Animal Drugs from Bulk Drug Substances Draft Guidance for Industry” (Draft Guidance).
Learn More